SEOM clinical guideline of diagnosis and management of low-grade glioma (2017)
Clin. transl. oncol. (Print)
; 20(1): 3-15, ene. 2018. tab, ilus
Artigo
em Inglês
| IBECS
| ID: ibc-170462
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Diffuse infiltrating low-grade gliomas include oligodendrogliomas and astrocytomas, and account for about 5% of all primary brain tumors. Treatment strategies for these low-grade gliomas in adults have recently changed. The 2016 World Health Organization (WHO) classification has updated the definition of these tumors to include their molecular characterization, including the presence of isocitrate dehydrogenase (IDH) mutation and 1p/19p codeletion. In this new classification, the histologic subtype of grade II-mixed oligoastrocytoma has also been eliminated. The precise optimal management of patients with low-grade glioma after resection remains to be determined. The risk-benefit ratio of adjuvant treatment must be weighed for each individual (AU)
RESUMEN
No disponible
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Contexto em Saúde:
ODS3 - Meta 3.8 Atingir a cobertura universal de saúde
/
ODS3 - Saúde e Bem-Estar
Problema de saúde:
Arranjos de Entrega
/
Meta 3.8 Atingir a cobertura universal de saúde
Base de dados:
IBECS
Assunto principal:
Glioma
/
Estadiamento de Neoplasias
Tipo de estudo:
Estudo diagnóstico
/
Guia de prática clínica
Limite:
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2018
Tipo de documento:
Artigo
Instituição/País de afiliação:
Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria/Spain
/
Hospital Regional Universitario Carlos Haya/Spain
/
Hospital Universitari I Politècnic la Fe/Spain
/
Hospital Universitari Son Espases/Spain
/
Hospital Universitario/Spain
/
Hospital de la Santa Creu I Sant Pau/Spain
